Page last updated: 2024-11-07

galactonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

galactonic acid: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

galactonic acid : A hexonic acid that has been found to increase in red blood cells of galactosemic patients. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

D-galactonic acid : A galactonic acid compound having D-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID128869
CHEBI ID16534
SCHEMBL ID193661
MeSH IDM0060412

Synonyms (19)

Synonym
CHEBI:16534
D-GALACTONATE ,
576-36-3
d-galactonic acid
C00880
galactonate
galactonic acid
EF258448-BB27-433E-84F8-8891061B9358
(2r,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanoic acid
13382-27-9
SCHEMBL193661
RGHNJXZEOKUKBD-MGCNEYSASA-N
sodium d-galactonate, >=98.0% (tlc)
Q27101959
J0M ,
A854394
DTXSID701316380
d-galactonicacid
DTXSID301045955

Research Excerpts

Overview

L-Galactonic acid is an intermediate in the eukaryotic pathway for d-galacturonic acid catabolism. Extracellular accumulation of l-galactsonic acid has not been reported.

ExcerptReferenceRelevance
"l-Galactonic acid is an intermediate in the eukaryotic pathway for d-galacturonic acid catabolism, but extracellular accumulation of l-galactonic acid has not been reported."( Engineering filamentous fungi for conversion of D-galacturonic acid to L-galactonic acid.
Hilditch, S; Kuivanen, J; Mojzita, D; Penttilä, M; Richard, P; Wang, Y; Wiebe, MG, 2012
)
1.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
galactonic acidA hexonic acid that has been found to increase in red blood cells of galactosemic patients.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Inner Membrane Transport7862
Galactitol and Galactonate Degradation1416

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (13.21)18.7374
1990's5 (9.43)18.2507
2000's20 (37.74)29.6817
2010's15 (28.30)24.3611
2020's6 (11.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.51 (24.57)
Research Supply Index3.99 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index43.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]